Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -16.47%363.31B | 3.89%526.27B | 10.17%1.8T | 18.08%495.61B | 6.64%424.52B | 5.47%434.93B | 26.35%506.57B | 4.37%1.63T | 8.42%419.71B | 0.65%398.08B |
Net interest income | 12.97%43.02B | -10.21%38B | -16.78%159.67B | -9.33%39.43B | -13.92%40.2B | -23.43%38.08B | -18.52%42.32B | -10.12%191.86B | -20.63%43.48B | -14.98%46.7B |
-Net interest income | -4.85%81.73B | -2.81%83.01B | 8.93%348B | 8.11%89.16B | 4.82%87.9B | 8.30%85.89B | 15.66%85.41B | 13.41%319.48B | 13.66%82.47B | 16.55%83.86B |
-Total interest expense | -19.03%38.71B | 4.47%45.01B | 47.57%188.33B | 27.57%49.73B | 28.38%47.7B | 61.66%47.81B | 96.73%43.08B | 87.04%127.62B | 119.35%38.99B | 118.24%37.16B |
Non interest income | -19.29%320.3B | 5.17%488.27B | 13.76%1.64T | 21.25%456.19B | 9.37%384.32B | 9.43%396.85B | 33.03%464.25B | 6.66%1.44T | 13.21%376.23B | 3.17%351.38B |
-Total premiums earned | -32.89%89.4B | -5.32%144.41B | 13.13%558.92B | 19.71%164.91B | 16.29%108.27B | -2.71%133.22B | 20.78%152.52B | 2.54%494.07B | 3.49%137.75B | -19.67%93.11B |
-Fees and commissions | -176.90%-31.16B | 8.37%97.87B | 423.86%136.28B | -22.20%18.39B | -22.93%51.88B | 213.14%40.52B | 410.01%90.31B | 143.63%26.02B | 258.56%23.64B | 323.86%67.32B |
-Other non interest income | 22.55%169.06B | 16.22%141.79B | 7.20%535.49B | 7.61%182.87B | 8.70%121.79B | 12.20%137.95B | -3.33%122B | 10.90%499.54B | 55.21%169.93B | -0.88%112.04B |
-Gain loss on sale of assets | 9.20%93B | 4.81%104.2B | -3.14%404.33B | 105.16%87.72B | 29.73%102.38B | -38.55%85.16B | -20.86%99.42B | -12.08%417.45B | -58.38%42.76B | -17.59%78.91B |
-Dividend income | ---- | ---- | 6.85%2.29B | ---- | ---- | ---- | ---- | 11.43%2.15B | ---- | ---- |
Credit losses provision | 13.97%-4.82B | 16.51%-2.5B | -158.32%-20.97B | -1,547.80%-6.76B | 5.72%-5.69B | -292.99%-5.6B | -1,106.45%-2.99B | -50.65%-8.12B | 42.90%-410M | -135.30%-6.03B |
Non interest expense | -30.87%241.34B | 3.74%432.55B | 11.65%1.42T | 22.28%392.12B | 9.72%324.88B | 3.13%349.13B | 32.37%416.96B | 5.12%1.27T | -1.57%320.68B | -2.26%296.11B |
Selling and administrative expenses | -9.44%314.11B | 2.17%359.78B | 11.65%1.41T | 22.18%389.6B | 9.75%322.54B | 3.13%346.86B | 12.57%352.13B | 5.22%1.26T | -1.42%318.87B | -2.24%293.9B |
-Selling and marketing expense | ---- | ---- | 22.30%106.65B | 22.60%28.26B | 20.45%27.58B | 30.18%28.28B | ---- | 13.72%87.2B | -3.37%23.05B | 11.08%22.9B |
-General and administrative expense | -1.40%314.11B | 2.17%359.78B | 10.86%1.3T | 22.15%361.34B | 8.84%294.96B | 1.26%318.58B | 20.06%352.13B | 4.64%1.17T | -1.26%295.82B | -3.22%271B |
Depreciation amortization depletion | ---- | ---- | 10.55%9.26B | 39.34%2.52B | 5.74%2.34B | 4.18%2.27B | ---- | -7.82%8.37B | -21.85%1.81B | -4.94%2.21B |
-Depreciation and amortization | ---- | ---- | 10.55%9.26B | 39.34%2.52B | 5.74%2.34B | 4.18%2.27B | ---- | -7.82%8.37B | -21.85%1.81B | -4.94%2.21B |
Other non-interest expense | ---- | 12.25%72.77B | ---- | ---- | ---- | ---- | --64.83B | ---- | ---- | ---- |
Income from associates and other participating interests | 78.67%20.76B | 42.76%7.76B | 66.54%36.77B | -138.28%-1.46B | 83.91%21.43B | 45.15%11.62B | 493.41%5.43B | -10.11%22.08B | -76.36%3.81B | 280.01%11.65B |
Special income (charges) | 122.33%4.94B | 2,898.73%26.06B | 121.99%70.76B | 932.60%59.83B | -55.80%7.85B | -58.42%2.22B | -70.98%869M | -79.61%31.88B | -96.01%5.79B | 281.49%17.75B |
Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---1.17B | ---156M | ---1.02B |
Less:Impairment of capital assets | -7.52%418M | 2.33%88M | -24.95%1.72B | 120.61%1.08B | -93.24%105M | 211.72%452M | -20.37%86M | -93.56%2.3B | -97.62%490M | -89.63%1.55B |
Gain on sale of business | 100.37%5.36B | 2,637.91%26.15B | 119.66%72.49B | 893.96%60.91B | -56.52%7.95B | -51.28%2.67B | -69.22%955M | -82.81%33B | -96.31%6.13B | -6.87%18.28B |
Other non-operating income (expenses) | -684.48%-6.03B | -37.97%-4.88B | 132.34%4.67B | 334.46%4.86B | 142.64%2.32B | 119.79%1.03B | -104.28%-3.53B | 29.52%-14.45B | 92.92%-2.07B | -202.45%-5.43B |
Income before tax | 43.91%136.82B | 34.43%120.17B | 19.84%469.98B | 50.70%159.97B | 4.70%125.54B | 18.02%95.08B | 4.47%89.39B | -23.02%392.18B | -44.93%106.15B | 25.03%119.9B |
Income tax | 39.40%39.86B | 38.72%35.01B | 37.95%131.39B | 47.70%39.01B | 33.62%38.56B | 52.35%28.59B | 18.95%25.24B | -48.96%95.25B | -69.16%26.41B | -12.27%28.86B |
Earnings from equity interest net of tax | ||||||||||
Net income | 45.85%96.97B | 32.74%85.16B | 14.03%338.59B | 51.69%120.96B | -4.46%86.99B | 7.59%66.48B | -0.30%64.16B | -8.03%296.93B | -25.56%79.74B | 44.50%91.05B |
Net Income continuous operations | 45.85%96.97B | 32.74%85.16B | 14.03%338.59B | 51.69%120.96B | -4.46%86.99B | 7.59%66.48B | -0.30%64.16B | -8.03%296.93B | -25.56%79.74B | 44.50%91.05B |
Noncontrolling interests | -44.11%754M | -231.91%-1.57B | -214.44%-7.55B | -550.87%-5.97B | -386.71%-4.12B | -4.12%1.35B | -50.91%1.19B | 20.38%6.59B | 21.38%1.32B | 187.09%1.44B |
Net income attributable to the company | 47.71%96.21B | 37.75%86.74B | 19.22%346.13B | 61.86%126.93B | 1.67%91.11B | 7.86%65.13B | 1.68%62.97B | -8.52%290.34B | -26.04%78.42B | 38.59%89.61B |
Net income attributable to common stockholders | 47.71%96.21B | 37.75%86.74B | 19.22%346.13B | 61.86%126.93B | 1.67%91.11B | 7.86%65.13B | 1.68%62.97B | -8.52%290.34B | -26.04%78.42B | 38.59%89.61B |
Diluted earnings per share | 49.90%84.02 | 39.97%75.4 | 21.37%298.55 | 64.23%109.87 | 3.42%78.91 | 9.90%56.05 | 3.70%53.87 | -6.73%245.98 | -24.45%66.9 | 41.30%76.3 |
Basic earnings per share | 49.87%83.87 | 39.93%75.28 | 21.33%298.05 | 64.19%109.66 | 3.39%78.78 | 9.88%55.96 | 3.66%53.8 | -6.75%245.65 | -24.48%66.79 | 41.27%76.2 |
Dividend per share | 45.26%62.17 | --0 | 15.19%98.6 | 30.37%55.8 | --0 | 0.00%42.8 | --0 | 0.00%85.6 | -8.15%42.8 | --0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |